Publications

Elimination of highly multidrug-resistant wound bacteria by the lactic acid bacterial drug candidate ILP100

Lofton Tomenius H et al. · Infectious Diseases and Therapy

Oral administration of CXCL12 expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models

Öhnstedt E et al. · American Journal of Physiology – Gastrointestinal and Liver Physiology

Localized immunotherapy for colitis: breakthroughs with CXCL12-expressing Limosilactobacillus reuteri

Mishra A · American Journal of Physiology – Gastrointestinal and Liver Physiology

Engineered bacteria to accelerate wound healing: an adaptive, randomized, double-blind, placebo-controlled, first-in-human phase 1 trial

Öhnstedt E et al. · eClinicalMedicine (Lancet Discovery Science)

Accelerated wound healing in minipigs by on-site production and delivery of CXCL12 by transformed lactic acid bacteria

Öhnstedt E et al. · Pharmaceutics 14(2):229

Distinct B cell subsets in Peyer's patches convey probiotic effects by Limosilactobacillus reuteri

Liu H et al. · Microbiome 9(198)

Perivascular macrophages regulate blood flow following tissue damage

Vågesjö E et al. · Circulation Research 128(11):1694-1707

The healing power of neutrophils

Phillipson M, Kubes P · Trends in Immunology 40(7):635-647

Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria

Vågesjö E et al. · PNAS 115(8):1895–1900

In vivo and in vitro detection of luminescent and fluorescent Lactobacillus reuteri and application of red fluorescent mCherry for assessing plasmid persistence

Karimi S et al. · PLOS ONE 11(3):e0151969